Table 2.
Adverse events reported in the study
| Event | Placebo | Ivermectin | p value |
|---|---|---|---|
| Heartburn | 1 | 0 | 0.652 |
| Anxiety | 0 | 1 | 0.348 |
| Cystitis | 0 | 1 | 0.348 |
| Nasal congestion | 2 | 0 | 0.201 |
| Back pain | 1 | 0 | 0.652 |
| Encephalitis | 0 | 1 | 0.348 |
| Peptic acid disease | 1 | 0 | 0.652 |
| Exanthema | 0 | 1 | 0.348 |
| Pharyngitis | 1 | 0 | 0.652 |
| Gastritis | 1 | 1 | 0.844 |
| Acute gastritis | 1 | 0 | 0.652 |
| Hyperglycaemia | 1 | 0 | 0.652 |
| Arterial hypertension | 1 | 1 | 0.844 |
| Urinary tract infection | 0 | 2 | 0.094 |
| Leucocytosis | 1 | 0 | 0.652 |
| Elevated lipase | 1 | 0 | 0.652 |
| Low back pain | 1 | 0 | 0.652 |
| Dizziness | 1 | 0 | 0.652 |
| Nausea | 1 | 2 | 0.713 |
| Pneumonia | 1 | 0 | 0.652 |
| Right ear otitis | 1 | 0 | 0.652 |
| Maculopapular pruritus | 0 | 1 | 0.348 |
| Skin rash | 1 | 0 | 0.652 |
| Gastroesophageal reflux | 1 | 0 | 0.652 |
| Heat rash | 1 | 0 | 0.652 |
| Tachycardia | 1 | 0 | 0.348 |
| Vertigo | 0 | 1 | 0.348 |
Values in frequency. Pearson χ2 test